Conversely, in patients whose auxiliary diagnostic parameters—such as PSA density—do not independently indicate prostate cancer, a PI-RADS 3 ratio exceeding 0.026 may justify the recommendation for prostate biopsy or the implementation of a more stringent follow-up protocol. This evidence concerns the gene KLK3 and prostate carcinoma.